Filing Details
- Accession Number:
- 0001144204-11-031358
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-20 14:22:44
- Reporting Period:
- 2011-05-18
- Filing Date:
- 2011-05-20
- Accepted Time:
- 2011-05-20 14:22:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1077183 | Neogenomics Inc | NGNM.OB | Services-Testing Laboratories (8734) | 742897368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1518730 | W Mark Smits | C/O Neogenomics, Inc. 12701 Commonwealth Drive Suite 9 Fort Myers FL US 33913 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-18 | 45,000 | $1.02 | 45,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-18 | 45,000 | $1.37 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (Right to Buy) | Disposition | 2011-05-18 | 45,000 | $0.00 | 45,000 | $1.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-08-30 | 2015-08-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,667 | Direct |
Footnotes
- On August 30, 2010 Mr. Smits was granted an option to purchase 425,000 shares of common stock. The first date that options became exercisable was August 30, 2010 and the remaining options vest based on time and performance based criteria.
- Mr. Smits has resigned his position with NeoGenomics, Inc. As a result he does not have any further beneficial ownership of derivative securities.
Billionaire Hedge Funds
